1994
DOI: 10.1016/0378-5173(94)90236-4
|View full text |Cite
|
Sign up to set email alerts
|

Design and testing in vitro of a bioadhesive and floating drug delivery system for oral application

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
34
0

Year Published

2001
2001
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 146 publications
(35 citation statements)
references
References 12 publications
1
34
0
Order By: Relevance
“…It was interesting to note that the tablets floated in less than 30 sec in the dissolution cell of the FTC apparatus during the in vitro dissolution study (dynamic test) (Figure 3), compared with the beaker method (static test) (Figure 4). This observation has been also pointed out by Jiménez-Castellanos et al (44) where sotalol HCl tablets floated after 27.7 min in the beaker method under static conditions and after 10.3 min during the dissolution test using USP basket method.…”
Section: Resultssupporting
confidence: 57%
“…It was interesting to note that the tablets floated in less than 30 sec in the dissolution cell of the FTC apparatus during the in vitro dissolution study (dynamic test) (Figure 3), compared with the beaker method (static test) (Figure 4). This observation has been also pointed out by Jiménez-Castellanos et al (44) where sotalol HCl tablets floated after 27.7 min in the beaker method under static conditions and after 10.3 min during the dissolution test using USP basket method.…”
Section: Resultssupporting
confidence: 57%
“…Tablets were crushed in a mortar and accurately average weighed amount of powdered tablets was taken for the analysis. [12] Samples were transferred to different volumetric flasks and were diluted up to the mark using 0.1 N HCl. The content was shaken well and kept for 30 minutes to dissolve the drug completely.…”
Section: Content Uniformitymentioning
confidence: 99%
“…Those formulations, which released calcium rapidly within the first couple of minutes of the experiment, corresponded to low T 50% values (F3, F7, F9, and F12). Several formulations had their T 50% 3 MgSt 0.1042 n/a n/a 0.52 4.47 n/a n/a b 4 HPMC*MgSt n/a -0.5038 6.5 n/a n/a n/a n/a b 5 HPMC*CA n/a n/a 6.0 n/a n/a n/a n/a b 6 MgSt*CA n/a -0.4363 n/a n/a n/a n/a n/a b 7 HPMC*HPMC n/a n/a n/a n/a n/a -3.35 -0.3927 b 8 CA*CA n/a n/a n/a n/a n/a n/a -0.3079 b 9 MgSt*MgSt 0.0518 -0.2569 5.62 n/a n/a n/a n/a R The values of another response variable, the release of calcium at 6 hours (Rel), of the 20 formulations were obtained directly from the calcium release profiles (Figures 1-3). Formulations with low T 50% values generally have a high Rel value ( Table 3).…”
Section: Release Propertiesmentioning
confidence: 99%
“…A gastric floating drug delivery system (GFDDS) [1][2][3][4][5][6][7][8] can overcome at least some of these problems and is particularly useful for drugs that are primarily absorbed in the duodenum and upper jejunum segments. The GFDDS is be able to prolong the retention time of a dosage form in the GI tract, thereby improving the oral bioavailability of the drug [2].…”
Section: Introductionmentioning
confidence: 99%